High Court Seeks Path To Limited Ruling On 'Skinny Labels'

By Ryan Davis

The U.S. Supreme Court on Wednesday appeared reluctant to craft new standards for deciding whether makers of generic drugs that use so-called skinny labels have encouraged others to infringe patents, with several justices saying existing law is sufficient to make a decision.

Transcript attached | Read full article » | Save to favorites »

Novo Nordisk Rejects Claim It Influences GLP-1 Market

By Aneeta Mathur-Ashton

Pharmaceutical giant Novo Nordisk told a Texas federal judge that it does not control the GLP-1 market and has not attempted to crush its competition in a bid to dismiss an antitrust suit it is facing.

Motion attached | Read full article » | Save to favorites »

AbbVie Seeks Early Win Over HHS In Botox Drug Price Suit

By Mark Payne

When the federal government included Botox in Medicare's drug price negotiation program, which allows Medicare officials to negotiate for lower drug prices, it overstepped its authority, drugmaker AbbVie Inc. told a D.C. federal court, arguing the cosmetic drug and migraine treatment is a "plasma-derived" product ineligible for price controls.

Motion attached | Read full article » | Save to favorites »

PBMs Say Michigan AG Price-Fixing Suit Is Unsound

By Susan Smiley

Pharmacy benefit managers Express Scripts, Evernorth Health and Prime Therapeutics have bolstered their effort to escape a federal price-fixing suit brought against them by Michigan's attorney general by arguing the statutes cited in the complaint do not apply to them.

Brief attached | Read full article » | Save to favorites »

Squires Snubs 10 IPRs While 4 Pass Muster In Latest Order

By Theresa Schliep

U.S. Patent and Trademark Office Director John Squires rejected 10 petitions for America Invents Act patent reviews and granted four challenges in an order marking the roughly half-year mark since he took over the duty of making institution decisions.

Order attached | Read full article » | Save to favorites »

CEO Stole From His Company To Buy Mansion, SEC Says

By Jessica Corso

The former CEO of a California-based pharmaceutical company agreed Wednesday to pay the U.S. Securities and Exchange Commission $30,000 to end a lawsuit accusing him of misappropriating $3.2 million in company funds partly to buy a Beverly Hills mansion.

3 documents attached | Read full article » | Save to favorites »

Deloitte Can't Duck Bulk Of Vax Software Theft Suit

By Bryan Koenig

Deloitte must face an inventor's trade secrets misappropriation claims accusing the consulting giant of ripping off her firm's proprietary vaccination management system and securing a multimillion-dollar government contract to track the rollout of COVID-19 vaccines.

Order attached | Read full article » | Save to favorites »

J&J, Neutrogena Say FDA Signed Off On Benzene Products

By Jonathan Capriel

Johnson & Johnson Consumer Inc. and Kenvue Inc. are calling for a permanent end to a multistate consumer lawsuit claiming their Clean & Clear and Neutrogena acne treatments degrade into the cancer-causing chemical benzene, arguing in New Jersey federal court that federal regulators have already determined that the key ingredient is safe.

Motion attached | Read full article » | Save to favorites »

Bausch Balks At Suspected Tweak In Price-Fixing Deals

By Brian Steele

A stipulation between state attorneys general and private plaintiffs suing generic-drug makers for alleged price-fixing seems to reflect a change in the states' earlier deal to release claims against Bausch entities, the companies said in asking a Connecticut federal judge to maintain the status quo.

2 documents attached | Read full article » | Save to favorites »

Analysis

3 Federal Circuit Clashes To Watch In May

By Ryan Davis

The Federal Circuit's May argument slate includes appeals of invalidity decisions and sanctions tied to VLSI Technology's multibillion-dollar chip patent dispute with Intel, as well as Amazon's challenge to a cloud storage patent verdict against it for over half a billion dollars.

Read full article » | Save to favorites »

Feds Say Lack Of Injury Dooms Gold Card Program Challenge

By Tom Lotshaw

The Trump administration said a suit challenging the gold card visa program's legality must be thrown out because the immigrants and academic professionals union that filed it can't show the program hurts their chances at getting visas.

Motion attached | Read full article » | Save to favorites »

Ropes & Gray Guides Italy's Chiesi On $1.9B US Biotech Deal

By Al Barbarino

Chiesi Group said Wednesday it will acquire KalVista Pharmaceuticals in a deal valued at about $1.9 billion, expanding the Italian biopharmaceutical company's rare disease portfolio with a newly approved treatment for a rare hereditary swelling disorder. 

Read full article » | Save to favorites »

Teva Acquires Tourette's Drugmaker For Up To $900M

By Jade Martinez-Pogue

Biopharmaceutical company Teva Pharmaceuticals, advised by Faegre Drinker Biddle & Reath LLP, on Wednesday announced plans to acquire Bradley Arant Boult Cummings LLP-advised Emalex Biosciences for up to $900 million.

Read full article » | Save to favorites »

Hogan Lovells Rehires Baker McKenzie Chair As Partner In DC

By Jack Rodgers

Hogan Lovells has rehired an attorney who was most recently the chair of Baker McKenzie's U.S. healthcare and life sciences regulatory practice, who advises life sciences, food, consumer platform and technology companies.

Read full article » | Save to favorites »

How To Gear Up For Trump's Pharma Tariffs

President Donald Trump's proclamation establishing tariffs on certain pharmaceutical products holds a few areas of ambiguity that companies should review and prepare for before the tariffs come into effect later this year, say attorneys at Arnold & Porter.

Read full article » | Save to favorites »

Improving Well-Being In Law, 10 Years After Landmark Study

An important 2016 study revealed significant substance abuse and mental health issues among lawyers, and while the findings helped normalize the conversation around these topics, a decade later, structural change is still needed, says Denise Robinson at PLI.

Read full article » | Save to favorites »

Analysis

Comey Indictment Built On Bad Legal Foundation, Experts Say

By Phillip Bantz

The criminal indictment of former FBI Director James B. Comey over an alleged threat against President Donald Trump by way of a social media post of seashells appears to be based on either an outdated or flawed understanding of the legal standard required to prove the charges in the case, which could sink the prosecution, according to experts.

Indictment attached | Read full article » | Save to favorites »

GrayRobinson Faces More Suits Over 2025 Data Breach

By Adrian Cruz

After being hit with a proposed class action accusing GrayRobinson PA of negligence following the revelation of a March 2025 data breach, the Florida-based firm is now facing two further suits regarding the same incident.

2 documents attached | Read full article » | Save to favorites »

Justices Limit Voting Rights Act Suits While Voiding La. Map

By Katie Buehler

The U.S. Supreme Court struck down Louisiana's congressional map containing two majority-Black voting districts Wednesday and further limited the Voting Rights Act's use in challenging racial discrimination in legislative redistricting — a decision the dissent claims completes the conservative majority's "demolition" of the seminal civil rights law.

2 documents attached | Read full article » | Save to favorites »

Fla. Judge Pick Denies Conflict In Trump Defamation Case

By Courtney Bublé

A judicial nominee for the Southern District of Florida on Wednesday denied there was any overlap between when he presided over a case involving President Donald Trump and when the White House let him know Trump was considering him for the federal judgeship.

Read full article » | Save to favorites »

Judiciary Advisers Back Looser Limits On Defense Subpoenas

By Jeff Overley

A campaign by white collar defense lawyers against long-standing limits on subpoena powers cleared a key hurdle Wednesday when federal judiciary advisers endorsed earlier and easier access to potentially favorable evidence despite staunch resistance from crime victims' advocates.

1 document attached | Read full article » | Save to favorites »

Former AG Bondi To Appear Before House Committee May 29

By Courtney Bublé

Former Attorney General Pam Bondi will appear before the House oversight committee on May 29, committee Republicans said Wednesday.

1 document attached | Read full article » | Save to favorites »

Nadine Menendez Denied Bail During Bribery Conviction Appeal

By George Woolston

A New York federal judge on Wednesday denied a bid from Nadine Menendez for bail while she appeals her conviction on a bribery scheme carried out with her ex-senator husband, ruling that her motion doesn't raise a substantial question of law.

Decision attached | Read full article » | Save to favorites »